Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype
about
Improvement of Asthma and Gastroesophageal Reflux Disease With Oral Pulvis stomachicus cum Belladonna, a Combination of Matricaria recutita, Atropa belladonna, Bismuth, and Antimonite: A Pediatric Case Report.An updated review on gastro-esophageal reflux in pediatrics.Reply: worsening asthma control in children taking lansoprazole: possible mechanismsLansoprazole worsens asthma control in poor metabolizers: is nitric oxide involved?Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.
P2860
Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Lansoprazole Is Associated wit ...... C19 Poor Metabolizer Phenotype
@ast
Lansoprazole Is Associated wit ...... C19 Poor Metabolizer Phenotype
@en
type
label
Lansoprazole Is Associated wit ...... C19 Poor Metabolizer Phenotype
@ast
Lansoprazole Is Associated wit ...... C19 Poor Metabolizer Phenotype
@en
prefLabel
Lansoprazole Is Associated wit ...... C19 Poor Metabolizer Phenotype
@ast
Lansoprazole Is Associated wit ...... C19 Poor Metabolizer Phenotype
@en
P2093
P2860
P1476
Lansoprazole Is Associated wit ...... C19 Poor Metabolizer Phenotype
@en
P2093
American Lung Association-Airways Clinical Research Centers
Christine Y Wei
Edward B Mougey
Janet T Holbrook
Jason E Lang
John J Lima
Robert A Wise
W Gerald Teague
P2860
P304
P356
10.1513/ANNALSATS.201408-391OC
P577
2015-06-01T00:00:00Z